Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 28 of the 61 sources its claims cite were checked for support.

Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled Trial

Open access

Abstract

Background: Health anxiety is a prevalent and debilitating disorder associated with extensive use of healthcare services and reduced quality of life (QoL). Regional variability in specialised clinics or specialist healthcare providers limits access to evidence-based treatment, which may be overcome by internet-delivered Acceptance and Commitment Therapy (iACT). Objective: This study investigated the cost effectiveness of iACT for severe health anxiety in adults. Methods: Based on a Danish randomised controlled trial (March 2016–March 2017), the economic evaluation compared costs and effects between iACT and an active control condition (iFORUM). Effectiveness was measured using self-report questionnaires. The cost analysis applied a societal perspective. Resource use and healthcare costs were extracted from the Danish National Registries. Linear regression analysis was applied using change in costs/effectiveness outcomes as the dependant variable. Time, group, and interaction between time and group were independent variables. The primary outcome was the proportion of clinically significant improvements, defined as a ≥ 25% reduction in two measures of health anxiety. The probability of cost effectiveness was presented in a cost-effectiveness acceptability curve for a range of threshold values for willingness to pay. Results: No significant differences were detected in healthcare costs between groups; however, the iACT group significantly improved in all effectiveness outcomes. The economic analysis showed that, from the healthcare perspective, iACT was associated with an incremental cost-effectiveness ratio of €33 per additional case of clinically significant improvement compared with iFORUM and that, from the societal perspective, iACT dominated iFORUM because it was more effective and less expensive. Conclusions: We found no statistically significant differences in costs between groups; however, iACT for severe health anxiety may be cost effective, as evidenced by significant differences in effect. Trial Registry Number: Clinicaltrials.gov, no. NCT02735434. © 2022, The Author(s).

Overview

CoChat Summary

TL;DR

In this Danish randomized controlled economic evaluation, 12-week clinician-guided internet-delivered Acceptance and Commitment Therapy (iACT) for severe health anxiety improved outcomes more than an active online forum control (iFORUM). It did not significantly change healthcare costs, but it appeared cost-effective: €33 per additional clinically significant improvement from the healthcare perspective and dominant from the societal perspective.

Key findings

  • At 6-month follow-up, twice as many iACT patients as iFORUM patients achieved a clinically significant improvement (risk ratio 2.09; 95% CI 1.3–3.3; p = 0.002).
  • No significant differences were detected in healthcare costs between groups.
  • From the healthcare perspective, the incremental cost-effectiveness ratio was €33 per additional case of clinically significant improvement; sensitivity analysis reduced this to €6.
  • From the societal perspective, iACT dominated iFORUM because it was more effective and less expensive; the probability of being cost effective was close to 100% at a willingness-to-pay threshold of €6000.

Methods

  • Secondary economic evaluation alongside a Danish randomized controlled trial (March 2016–March 2017), with 101 adults randomized 1:1 to iACT (n = 53) or iFORUM (n = 48).
  • Costs were analyzed from a societal perspective using registry-based primary care, secondary care, and productivity-loss data; follow-up extended from baseline to 6-month follow-up (reported as 10 months after baseline).
  • Effectiveness was assessed with self-report measures (WI-7 primary, SHAI secondary, WHO-5), using linear regression with a difference-in-differences approach; cost-effectiveness uncertainty was assessed with bootstrapping and cost-effectiveness acceptability curves.

Limitations

  • The paper states that the study was powered mainly for effectiveness outcomes, and the authors note that the relatively small sample size may explain the non-significant cost differences.
  • Pre-baseline measurements were not available, which the authors say limits testing of the parallel-trends assumption required for the difference-in-differences analysis.
  • The paper states that health-related quality-of-life measures were not collected, so a cost-utility analysis using QALYs was not possible.
  • Evident from the text: prescribed medication outside hospitals was unavailable, patients’ personal/travel time was not included, and the active control (iFORUM) may have limited ecological validity because usual care rarely consists of discussion forums.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s41669-021-00319-x

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Study outline
Fig. 1 Study outlineCC BY-NC · PubMed Central
Fig. 2 Bootstrapped replicates of differences in costs and effects between iACT and iFORUM in base-case and sensitivity analyses applying societal and healthcare cost perspectives
Fig. 2 Bootstrapped replicates of differences in costs and effects between iACT and iFORUM in base-case and sensitivity analyses applying societal and healthcare cost perspectivesCC BY-NC · PubMed Central
Fig. 3 Cost-effectiveness acceptability curves for base-case and sensitivity analyses applying societal and healthcare costing perspectives. SHAI Health Anxiety Inventory Short Form, WHO-5 WHO Well-being Index, WI-7 Whiteley Index
Fig. 3 Cost-effectiveness acceptability curves for base-case and sensitivity analyses applying societal and healthcare costing perspectives. SHAI Health Anxiety Inventory Short Form, WHO-5 WHO Well-being Index, WI-7 Whiteley IndexCC BY-NC · PubMed Central

Verification

Claims the paper makes

19 Valid · 2 Not valid · 11 Not checked · 57 Own results and interpretations

34 more claims · 3 with their cited sources checked

Create a free account to see all 89 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 34

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Cited by

See all 11

Metadata

Authors
Risør, B. W., Frydendal, D. H., Villemoes, M. K., Nielsen, C. P., Rask, C. U., & Frostholm, L.
Affiliations
  • Central Denmark Region (DK)
  • Aarhus University Hospital (DK)
  • Aarhus University (DK)
Corresponding author
Risør, Bettina Wulff
Venue
PharmacoEconomics - Open
Published
2022-01-08
Volume
6
Issue
2
Pages
179-192
ISSN
  • 2509-4254 (ISSN-L)
  • 2509-4262
OpenAlex
W4205812032
Cited by
11
References
50
Citations by year
2025: 5 · 2024: 4 · 2023: 2
FWCI
2.20
Type
journal article
Language
en
Open access
Licence
Locations
  • PharmacoEconomics - Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
TrygFonden (17-B-0213)
Topics
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
Keywords
health anxiety, online therapy, acceptance and commitment therapy, cost-effectiveness, health care costs, societal perspective, quality of life, access to mental health care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled Trial. https://app.cochat.ai/papers/10.1007/s41669-021-00319-x
The paper
Risør, B. W., Frydendal, D. H., Villemoes, M. K., Nielsen, C. P., Rask, C. U., & Frostholm, L. (2022). Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled Trial. PharmacoEconomics - Open. https://doi.org/10.1007/s41669-021-00319-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.